{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
HOOKIPA Pharma, Inc.
Is HOOKIPA Pharma, Inc. technically bullish or bearish?
As of May 23, 2025, HOOKIPA Pharma, Inc. shows a mildly bearish trend, driven by bearish daily moving averages and Bollinger Bands, despite some mildly bullish signals from the weekly MACD and KST.
Who are in the management team of HOOKIPA Pharma, Inc.?
As of March 2022, the management team of HOOKIPA Pharma, Inc. includes Prof. Jan van de Winkel (Chairman), Mr. Joern Aldag (CEO), Dr. Reinhard Kandera (CFO), and several independent directors. They are responsible for the company's strategic direction and operations.
What does HOOKIPA Pharma, Inc. do?
HOOKIPA Pharma, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for infectious diseases and cancer. As of March 2025, it has a market cap of $15.97 million, with net sales of $2 million and a net loss of $15 million.
How big is HOOKIPA Pharma, Inc.?
As of Jun 18, HOOKIPA Pharma, Inc. has a market capitalization of 15.97 million, with net sales of 9.34 million and a net profit of -73.31 million over the latest four quarters. The company reported shareholder's funds of 51.21 million and total assets of 82.55 million as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
